March 3, 2017
The Ministry of Health, Labor and Welfare (MHLW) has withdrawn orphan drug designations for three drugs including Nippon Zoki Pharmaceutical’s rabbit-derived antilymphocyte immunoglobulin Zetbulin. Zetbulin, a treatment for aplastic anemia, saw its designation withdrawn due to the discontinuation of its...read more